Skip to main content

Z3Dlab

MaterialsChaumontel, Ile-de-France, FranceFounded 2014· One of 955 Materials companies tracked by AMPulse

Specializes in ultra-precise 3D printing for micro-assemblies, producing miniature components with micron-level accuracy for industries like electronics, medical devices, and aerospace.

CEO / Founder
Madjid Djemai
Team Size
1-10
Stage
Active
Total Funding
$10.7M
Latest Round
Series A
Key Investors
French National Research Agency; HS HI-TECH

Technology & Products

Key Products

["ZTi-Powder","ZTi-Med"]

Technological Advantage

Improved ductility, wear resistance and heat oxidation compared to traditional alloys.

Differentiation

Value Proposition

Develops engineered bone implants using advanced 3D printing, focusing on biocompatible, durable, and customizable solutions for patient-specific bone defects.

How They Differentiate

Titanium zirconium alloy powders designed to replace existing alloys in critical engineering and medical additive manufacturing applications.

Market & Competition

Target Customers

Industries like electronics, medical devices, and aerospace

Industry Verticals

["Aeronautics","Medical"]

Competitors

Sintavia; Stratasys; Metalysis

Growth & Milestones

Growth Metrics

Participates in ANR project OPTIMAA with LSPM (project ID ANR-23-LCV2-0002, ongoing as of 2023).

Major Milestones

["Partnership with 6K Additive","Development of ZTi-Powder and ZTi-Med materials"]

Notable Customers

6K Additive

Why this company matters

Z3Dlab positions itself as a materials specialist in metal additive manufacturing, focusing on titanium-zirconium alloy powders that aim to replace conventional alloys in demanding applications. Founded in 2014 and based in Chaumontel, France, the company competes in the LPBF materials segment, ranking 50th among 114 active competitors.

The company's core products are ZTi-Powder and ZTi-Med, patented titanium-ceramic composite powders designed for laser powder bed fusion. These materials claim improved ductility, wear resistance, and heat oxidation performance compared to traditional titanium alloys. The powders target two primary verticals: aeronautics and medical devices.

In the medical space, Z3Dlab focuses on engineered bone implants that are biocompatible, durable, and customizable for patient-specific bone defects. The company has partnered with 6K Additive, a notable customer and partner, to scale production and distribution. It also participates in the ANR project OPTIMAA with LSPM, a research collaboration ongoing as of 2023.

Z3Dlab has raised $10.7 million from investors including the French National Research Agency and HS HI-TECH. CEO Madjid Djemai brings two decades of energy-sector experience across multiple continents. The company's main competitive risk lies in the narrow adoption of its proprietary powders versus established Ti-6Al-4V grades, which dominate medical and aerospace LPBF applications.